Replimune (REPL) awards stock options and RSUs to director Astley-Sparke
Rhea-AI Filing Summary
Replimune Group director Philip Astley-Sparke reported compensation-related equity awards. He received a stock option for 75,000 shares of common stock at an exercise price of 7.6100 per share, expiring on April 1, 2036. Twenty-five percent of this option vests on April 1, 2027, with the rest vesting in 36 approximately equal monthly installments.
He also received 50,000 shares of common stock issuable upon settlement of restricted stock units, with 25% vesting on May 15, 2027 and the remainder in three approximately equal annual installments through May 15, 2030, subject to continuous service. Following the grant, he directly holds 1,430,071 common shares. These are grants/awards, not open-market purchases or sales.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 50,000 shares
Net Buy
2 txns
Insider
Astley-Sparke Philip
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 75,000 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 50,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 75,000 shares (Direct);
Common Stock — 1,430,071 shares (Direct)
Footnotes (2)
- F1. Represents shares of the Issuer's common stock issuable upon settlement of restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs will vest on May 15, 2027 and the remainder will vest in three approximately equal annual installments thereafter until May 15, 2030, subject to the Reporting Person's continuous service to the Issuer.
- F2. 25% of the shares underlying this stock option vest on April 1, 2027, and the remainder of the shares underlying this stock option vest in 36 approximately equal monthly installments thereafter.
Key Figures
Stock option grant size: 75,000 shares
Option exercise price: 7.6100 per share
Option expiration: April 1, 2036
+3 more
6 metrics
Stock option grant size
75,000 shares
Stock Option (right to buy) granted on April 1, 2026
Option exercise price
7.6100 per share
Exercise price for 75,000-share stock option
Option expiration
April 1, 2036
Expiration date of stock option grant
RSU grant size
50,000 shares
Common stock issuable upon RSU settlement granted April 1, 2026
RSU initial vesting date
May 15, 2027
25% of RSUs vest on this date
Shares after grant
1,430,071 shares
Total common shares directly held after common stock grant
Key Terms
restricted stock units ("RSUs"), Stock Option (right to buy), exercise price, vesting, +1 more
5 terms
restricted stock units ("RSUs") financial
"Represents shares of the Issuer's common stock issuable upon settlement of restricted stock units ("RSUs") granted to the Reporting Person."
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
Stock Option (right to buy) financial
"security_title": "Stock Option (right to buy)""
exercise price financial
"conversion_or_exercise_price": "7.6100""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"25% of the RSUs will vest on May 15, 2027 and the remainder will vest in three approximately equal annual installments thereafter"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
expiration date financial
"expiration_date": "2036-04-01T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider equity awards did REPL director Philip Astley-Sparke report?
Philip Astley-Sparke reported receiving a stock option for 75,000 shares and 50,000 restricted stock units in Replimune Group. Both awards are compensation-related grants, with multi-year vesting schedules starting in 2027 and no open-market share purchases or sales disclosed.
How many Replimune (REPL) options were granted to Philip Astley-Sparke?
He was granted a stock option covering 75,000 shares of Replimune common stock. The option has an exercise price of 7.6100 per share, vests over roughly four years beginning April 1, 2027, and expires on April 1, 2036 if not exercised.
What are the vesting terms for Philip Astley-Sparke’s RSUs at Replimune (REPL)?
The 50,000 RSUs vest 25% on May 15, 2027, with the remaining units vesting in three approximately equal annual installments until May 15, 2030. Each vested restricted stock unit settles into one share of Replimune common stock, contingent on continued service.
Are the Replimune (REPL) Form 4 transactions open-market buys or sales?
The transactions are not open-market trades. They are grants or awards of a 75,000-share stock option and 50,000 restricted stock units, both issued at a transaction price of 0.0000 per share as part of compensation, with defined vesting schedules and no immediate cash purchase or sale.